Table 1.
miRNA | CSC Origin * | Direct/Indirect Targets | Effects on CSC Properties | Ref. No. | |
---|---|---|---|---|---|
Induction | Suppression | ||||
miR-1 | COAD | Notch3/Asef | Growth Migration Invasion | [22,64] | |
miR-25 | LIHC | PTEN/PI3K/Akt/Bad | Resistance to TRAIL-induced apoptosis | [65] | |
miR-146a | BRCA | Notch/NF-κB | Self-renewal | [66] | |
miR-143 | PCPG | Notch 1-3 | Self-renewal | [22] | |
miR-708-5p | LUAD LUSC | Wnt/β-catenin | Stemness and related pathogenesis | [23,67] | |
miR-19a miR-19b | LUAD | Wnt/β-catenin | Tumorigenicity | [23,68] | |
miR-451 | COAD | Wnt | Self-renewal Tumorigenicity Drug resistance |
[69,70,71] | |
miR-15a | COAD | YAP1, DCLK1, BMI1, Bcl2 | Stemness | [72] | |
miR-1246 |
@ NSCLC PAAD |
MT1G CCNG2 |
Stemness Drug resistance | [73,74] | |
miR-548c-3p | PRAD | unknown | Self-renewal Radioresistance | [75] | |
miR-320 | PRAD | Wnt/β-catenin | Self-renewal Stemness |
[70,76] | |
miR-589-5p | LIHC | SOCS2/5/IL-6 PTPNI/11/IL-6 Stat3 | Spheroid formation Tumorigenesis Chemoresistance | [77] | |
miR-181 | LIHC | NLK/Wnt CDX2 GATA-binding protein 6 | Stemness | Differentiation | [78] |
miR-7 | BRCA | SETDB1/STAT3 | Proliferation Migration Invasion | [79] | |
miR-93 | BRCA | TGF-β/Jak1/AKT3/SOX4/STAT3 | MET CSC depletion | [80] | |
miR-193 | BRCA COAD | PLAU K-Ras | Tumorigenicity Invasion | [70,81] | |
miR-34 cluster | COAD PAAD LUAD BRCA PRAD | p53 Notch1/2 | Self-renewal Differentiation | [22,70,82] | |
miR-34a | PAAD PRAD | Bcl-2 Notch | Self-renewal | [22,83,84,85] | |
miR-34c-3p | GBM | Notch 2 | Proliferation | [22,82] | |
miR-200 cluster | BRCA COAD | Notch | Self-renewal Differentiation Metastasis | [70,85,86,87] | |
miR-200c miR-141 | PAAD BRCA | Notch | Drug resistance EMT | [22,88,89,90] | |
miR-22 | BRCA | TET enzymes/miR-200 | EMT Metastasis | [70,91,92,93] | |
miR-148a | LIHC | BMP/Wnt | Self-renewal Stemness | [94] | |
miR-302a/d | LIHC | E2F7/Akt1/β- catenin/Cyclin D | Self-renewal Proliferation | [95] | |
miR-17-92 | PAAD | Nodal/Activin/TGF-β | Self-renewal Stemness | [96,97] | |
miR-206 | BRCA | TWF1/MLK1-SRF/IL-11 | Self-renewal Invasion EMT | [98] | |
miR-199a | BRCA | LCOR/IFN | Self-renewal | [99] | |
miR-765 | SKCM | FOXA2 | Self-renewal | [100] | |
miR-126 | LCML | MAPK/ERK | Survival Self-renewal | [101,102,103] | |
miR-214 | LIHC | CTNNB1/Wnt EZH2/Wnt | CSC number | [104] | |
miR-1246 | LIHC | Axin2/β-catenin GSK3β/β-catenin | Stemness | [105] | |
Let-7b | LIHC | Frizzled4/Wnt | CSC number | [106] |
* NCI-based TCGA-based abbreviations (https://gdc.cancer.gov/resources-tcga-users/tcga-code-tables/tcga-study-abbreviations): COAD, Colon Adenocarcinoma; BRCA, breast cancer; PCPG, Pheochromocytoma and Paraganglioma; LUAD, Lung Adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD, Prostate Adenocarcinoma; PAAD, Pancreatic adenocarcinoma; GBM, Glioblastoma Multiform; LIHC, Liver Hepatocellular Carcinoma; SKCM, Skin Cutaneous Melanoma, LCML, Chronic Myelogenous Leukemia. @ NSCLC: Non small cell lung cancer.